RARß gene methylation is a candidate for primary glioblastoma treatment planning.

Atli, Emine Ikbal; Kalkan, Rasime; Özdemir, Muhsin; Aydin, Hasan Emre; Arslantas, Ali; Artan, Sevilhan

Atli, Emine Ikbal; Kalkan, Rasime; Özdemir, Muhsin; Aydin, Hasan Emre; Arslantas, Ali; Artan, Sevilhan.

Afiliación

Atli EI; Department of Medical Genetics, Faculty of Medicine, Trakya University, Edirne/Turkey.
Kalkan R; Department of Medical Genetics, Faculty of Medicine, Near East University, Nicosia, Turkish Republic of Northern Cyprus.
Özdemir M; Departments of Medical Genetics, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
Aydin HE; Departments of Neurosurgery, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
Arslantas A; Departments of Neurosurgery, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
Artan S; Departments of Medical Genetics, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.

Afr Health Sci ; 16(1): 218-26, 2016 Mar.

Article en En | MEDLINE | ID: mdl-27358635

Asunto(s)

Neoplasias Encefálicas/genética; Metilación de ADN; Glioblastoma/genética; Receptores de Ácido Retinoico/genética; Biomarcadores de Tumor; Neoplasias Encefálicas/mortalidad; Neoplasias Encefálicas/terapia; Femenino; Glioblastoma/mortalidad; Glioblastoma/terapia; Humanos; Masculino; Persona de Mediana Edad; Pronóstico; Receptores de Ácido Retinoico/metabolismo; Tasa de Supervivencia

Palabras clave

MS-HRM; RARß; methylation; primary glioblastoma multiforme

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Encefálicas / Receptores de Ácido Retinoico / Glioblastoma / Metilación de ADN Tipo de estudio: Guideline / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Afr Health Sci Asunto de la revista: MEDICINA / SERVICOS DE SAUDE Año: 2016 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google